Leptin as an immunocorrecting agent during normal pregnancy

Area of Science:

• Immunology
• Endocrinology
• Reproductive Biology

Background:

• Leptin, a hormone crucial for energy balance, also modulates immune function.
• Pregnancy involves significant hormonal shifts, including altered leptin levels, impacting maternal immunity.

Purpose of the Study:

• To investigate the effects of physiological leptin doses, relevant to pregnancy, on human peripheral blood mononuclear cells.
• To analyze leptin's impact on immune cell membrane molecule expression and cytokine production.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) from women were treated with leptin at pregnancy-specific doses.
• Flow cytometry was used to assess membrane molecule expression (HLA-DR, CD16, CD56).
• Cytokine production (TNF-alpha, IL-6, IL-2, IL-4, IL-10, IFN-alpha) was measured using ELISAs or similar assays.

Main Results:

• Leptin increased HLA-DR expression on T lymphocytes and stimulated TNF-alpha and IL-6 production.
• In first-trimester-equivalent doses, leptin boosted NK cell percentages (CD16+, CD56+) and IFN-alpha production.
• In second-to-third-trimester-equivalent doses, leptin decreased CD16+56+NKT cells while increasing NKT cells expressing CD16 and CD56.

Conclusions:

• Leptin significantly regulates immune cell function during pregnancy.
• Leptin modulates the expression of key membrane molecules and influences the production of specific cytokines by PBMCs.
• These findings highlight leptin's role in adapting maternal immune responses during gestation.